Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InModeINMD -0.86%85 Days Inventory is 271.16 as of Jun. 2026, which is 79% above its 10-year median of 151.30. GuruFocus rates INMD with a GF Score™ of 85/100 and a GF Value™ of $19.34 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, InMode ranks worse than 77.99% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). InMode's Average Total Inventories for the
three
months ended in Jun. 2026 was $71.5 Mil. InMode's Cost of Goods Sold for the
three
months ended in Jun. 2026 was $24.1 Mil.
Hence, InMode's Days Inventory for the
three
months ended in Jun. 2026 was 271.16.
The historical rank and industry rank for InMode's Days Inventory or its related term are showing as below:
INMD'
s Days Inventory Range Over the Past 10 Years
Min: 122.62 Med: 151.3 Max: 306.59
Current: 296.02
During the past 9 years, InMode's highest Days Inventory was 306.59. The lowest was 122.62. And the median was 151.30.
INMD's Days Inventory is ranked worse than 77.99% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 176.135
vs INMD: 296.02
InMode's Days Inventory
declined
from Jun. 2025 (314.20) to Jun. 2026 (271.16).
Inventory Turnover measures how fast the company turns over its inventory within a year.
InMode's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.34.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
InMode's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.75.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
InMode's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
InMode's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
InMode Days Inventory Related Terms
InMode Days Inventory Historical Data
* Premium members only.
The historical data trend for InMode's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InMode's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InMode Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InMode's Days Inventory distribution charts can be found below:
* The bar in red indicates where InMode's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InMode (INMD) has a Days Inventory of 271.16 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on InMode and its competitors. This is 79% above median its historical median of 151.30. Over the past decade, InMode's Days Inventory has ranged from 122.62 to 306.59. According to the industry distribution chart, InMode ranks #613 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 78%.
Is InMode's Days Inventory too high?
InMode's current Days Inventory of 271.16 is 79% above median its 10-year median of 151.30. Over the past 10 years, this metric has ranged from a low of 122.62 to a high of 306.59. The Medical Devices & Instruments industry median Days Inventory is 176.14. InMode's value of 271.16 is 54% above this industry median. Based on the distribution chart, InMode ranks #613 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, InMode has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does InMode's Days Inventory compare to BVS and PRCT?
According to the Medical Devices & Instruments industry distribution chart, InMode ranks #613 out of 786 companies for Days Inventory. This places InMode in the lower half of its industry. The industry median Days Inventory is 176.14. InMode's value of 271.16 is 54% above this benchmark. Historically, InMode's own Days Inventory has ranged from 122.62 to 306.59 over the past decade. While the company's 10-year median is 151.30 vs. the industry median of 176.14, InMode has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.14, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InMode's current Days Inventory of 271.16 is 54% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on InMode and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InMode's current Days Inventory is 271.16, which is 79% above median its own 10-year median of 151.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InMode stock overvalued right now?
Based on GuruFocus' analysis, InMode (INMD) is currently considered Modestly Undervalued. The stock's GF Value™ is $19.34, compared to a current price of $14.92 — trading 22.9% below its estimated fair value. The current Days Inventory is 271.16, which is 79% above median its 10-year median of 151.30 and 54% above the Medical Devices & Instruments industry median of 176.14. InMode's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For InMode (INMD), the current Days Inventory is 271.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InMode (INMD) Overvalued in 2026?
Based on GuruFocus' analysis, InMode stock appears to be undervalued.
The current stock price of $14.92 is trading 22.9% below its estimated GF Value™ of $19.34.
GuruFocus considers InMode to be Modestly Undervalued.
Key valuation signals for INMD:
Days Inventory: 271.16 (79% above median its 10-year median of 151.30)
GF Value™: $19.34 vs. price of $14.92 (22.9% below fair value)
Industry Position: 54% above the Medical Devices & Instruments median (#613 of 786)
No single metric tells the full story. See the INMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
85GF Score
Get the complete analysis for INMD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INMD has been successfully added to your 
